MedTrace Logo

Pilot Study of Unrelated Cord Blood Transplantation

NCT00916045 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-02-11

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and feasibility of unrelated double and single cord blood transplantation in patients with haematological malignancies using reduced-intensity or myeloablative conditioning regimens.

Conditions

Interventions

DRUG

Thiotepa

DRUG

Fludarabine

DRUG

Intravenous busulphan

DRUG

Thymoglobulin

DRUG

Ciclosporin

DRUG

Mycophenolate mofetil (MMF)

DRUG

Fludarabine

DRUG

Cyclophosphamide

RADIATION

Radiotherapy

DRUG

Thymoglobulin

DRUG

Ciclosporin

DRUG

Mycophenolate mofetil (MMF)

DRUG

Fludarabine

DRUG

Melphalan

DRUG

Thymoglobulin

DRUG

Ciclosporin

DRUG

Mycophenolate mofetil (MMF)

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    lead OTHER

Principal Investigators

  • Antonio Pagliuca, MBBS, MA, FRCP, FRCPath · King's College Hospital NHS Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00916045 on ClinicalTrials.gov